Evidence map›Paper›PMID 35145808›Full record

ArticleCureus2022

Peripheral Ossifying Fibroma Evolved From Pyogenic Granuloma.

Géssica V Godinho, Cristhiane A Silva, Bruno R Noronha, Everton J Silva, Luiz E Volpato

Abstract readCase Reports
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. [Peripheral ossifying fibroma. A series of cases].Revista cientifica odontologica (Universidad Cientifica del Sur)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Géssica V GodinhoDepartment of Dentistry, Hospital de Câncer de Mato Grosso, Cuiabá, BRA.
Cristhiane A SilvaProgram on Environment and Health, Universidade de Cuiabá, Cuiabá, BRA.
Bruno R NoronhaDepartment of Dentistry, Hospital de Câncer de Mato Grosso, Cuiabá, BRA.
Everton J SilvaDepartment of Dentistry, Hospital de Câncer de Mato Grosso, Cuiabá, BRA.
Luiz E VolpatoDepartment of Dentistry, Hospital de Câncer de Mato Grosso, Cuiabá, BRA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present article is to present the clinical case of a large peripheral ossifying fibroma that evolved from a previously diagnosed pyogenic granuloma in a 50-year-old woman. The patient was referred for treatment of a lesion over the buccal and palatal gingiva close to the left upper first molar. It was purplish-red in color, approximately 3 cm in diameter, having a smooth surface, a pedicled and bleeding base, with seven years of evolution, and diagnosed as pyogenic granuloma. After three years of evasion, the patient returned reporting an increase in the lesion and difficulty in eating. Clinically the nodule was lobular in appearance, pink in color and smooth, pediculated, firm in consistency, non-bleeding, about 5 cm in its greatest extension, extending to the maxillary tuberosity. The lesion was excised and referred for histopathological examination, which led to the diagnosis of peripheral ossifying fibroma. The patient was followed for approximately 18 months, prosthetically rehabilitated, with satisfactory healing and no clinical signs of recurrence. The possible evolution of a pyogenic granuloma to a peripheral ossifying fibroma was observed in this case, based on the histopathological changes that occurred, with the development of calcified material, fibrous maturation, and decreased vascular content of the initial lesion after three years.

Indexed as

excisional tissue biopsygingival growthgingival neoplasmsossifying fibromapyogenic granuloma

Identifiers

PMID35145808
PMCPMC8807426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.